THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION

Медицинский совет

S. A. Berns¹  R. I. Stryuk¹ 

[1] Moscow State University of Medicine and Dentistry named after Evdokimov, MoH RF;

关键词: hypertension;    renal protective effect;    ace inhibitors;    fosinopril;   

DOI  :  10.21518/2079-701X-2017-7-17-19

来源: DOAJ

【 摘 要 】

Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time, arterial hypertension (AH) is one of the most common CV pathologies, which, according to foreign researchers, affects about 30–45% of the general population [2] and about 40–47% of the population according to Russian studies. [3] The experts forecast that by 2030 the prevalence of hypertension will increase by approximately 10%. [4]

【 授权许可】

Unknown